maps.org, Written by Steven Nelson, Published: 22 June 2015
“Summary: U.S. News and World Report discusses the implications of about the Obama administration’s decision to eliminate the obstructive Public Health Service review previously required for marijuana research. The article details the additional barriers still standing in the way of marijuana research, most importantly the National Institute on Drug Abuse (NIDA)’s monopoly on government-approved marijuana for research purposes. The article describes MAPS’ upcoming clinical study of medical marijuana for PTSD in U.S. veterans, and investigates the changes that have led to this shift in policy. “We’re hoping the overall political environment has shifted enough where we will actually get permission from the DEA to start this farm and then we won’t have to go through NIDA at all,” explains Brad Burge of MAPS. “It’s a great opportunity for the Obama administration to show it’s progressive on marijuana issues. We’re pretty hopeful.”
Originally appearing here.
Medical marijuana advocates and researchers are celebrating a surprise decision by the Obama administration to scrap reviews that delayed – sometimes for years – private and state-funded research into marijuana’s medical value.
Researchers will no longer need to submit proposed pot studies to the U.S. Public Health Service for review, ending a hurdle that does not exist for research of other drugs listed as Schedule I substances – the controversial federal classification that puts marijuana alongside LSD and ecstasy.” CLICK THE LINK BELOW TO READ THE ENTIRE ARTICLE>>>>>